EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.1.1.96 | 3,5-dinitro-4-hydroxyphenylpyruvate + NADH |
- |
Bos taurus |
3,5-dinitro-4-hydroxyphenyllactate + NAD+ |
- |
r |
1.1.1.96 | 3-(3,5-dibromo-4-hydroxyphenyl)pyruvate + NADH |
- |
Bos taurus |
3-(3,5-dibromo-4-hydroxyphenyl)lactate + NAD+ |
- |
r |
1.1.1.96 | 3-(3,5-diiodo-4-hydroxyphenyl)pyruvate + NADH |
- |
Homo sapiens |
3-(3,5-diiodo-4-hydroxyphenyl)lactate + NAD+ |
- |
r |
1.1.1.96 | 3-(3,5-diiodo-4-hydroxyphenyl)pyruvate + NADH |
- |
Canis lupus familiaris |
3-(3,5-diiodo-4-hydroxyphenyl)lactate + NAD+ |
- |
r |
1.1.1.96 | 3-(3,5-diiodo-4-hydroxyphenyl)pyruvate + NADH |
formation of phenyllactic acids is strongly favoured |
Bos taurus |
3-(3,5-diiodo-4-hydroxyphenyl)lactate + NAD+ |
- |
r |
1.1.1.96 | 3-bromo-4-hydroxyphenylpyruvate + NADH |
- |
Bos taurus |
3-bromo-4-hydroxyphenyllactate + NAD+ |
- |
r |
1.1.1.96 | 3-fluorophenylpyruvate + NADH |
- |
Bos taurus |
3-fluorophenyllactate + NAD+ |
- |
r |
1.1.1.96 | 4-hydroxyphenylpyruvate + NADH + H+ |
- |
Homo sapiens |
4-hydroxyphenyllactate + NAD+ |
- |
r |
1.1.1.96 | 4-hydroxyphenylpyruvate + NADH + H+ |
- |
Bos taurus |
4-hydroxyphenyllactate + NAD+ |
- |
r |
1.1.1.96 | indolepyruvate + NADH |
- |
Bos taurus |
indolelactate + NAD+ |
- |
r |